USFDA concludes inspection at Zydus Cadila’s API manufacturing facilities in Ankleshwar

27 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has inspected the Zydus Cadila’s API manufacturing facility located at Ankleshwar in Gujarat. The inspection was conducted from July 22, 2019 to July 26, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

1013.75 14.15 (1.42%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.